Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
449.4 USD | +0.43% | +2.03% | +10.49% |
22/05 | Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing | MT |
21/05 | ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.49% | 12TCr | |
+12.10% | 11TCr | |
-4.45% | 2.47TCr | |
-2.33% | 2.2TCr | |
-6.03% | 1.93TCr | |
-13.47% | 1.76TCr | |
-40.50% | 1.73TCr | |
+5.95% | 1.4TCr | |
+30.52% | 1.21TCr | |
-34.02% | 776.53Cr |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Canaccord Genuity Initiates Coverage on Vertex Pharmaceuticals With Hold Rating, $311 Price Target